Zynex, Inc. (ZYXI)
After hours:
| Previous close | 10.34 |
| Open | 10.44 |
| Bid | 10.46 x 200 |
| Ask | 10.50 x 200 |
| Day's range | 10.44 - 10.78 |
| 52-week range | 6.88 - 13.77 |
| Volume | |
| Avg. volume | 179,495 |
| Market cap | 333.322M |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | 45.61 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 05 Jan 2022 |
| 1y target est | N/A |
- PR Newswire
Zynex to Present at the RBC Capital Markets Global Healthcare Conference
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held May 14-15, 2024.
- PR Newswire
Zynex Executives Recognized Among Top 25 in Medical Technology
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today is proud to announce that two of our executives have been featured among Medical Technology's Top 25 by The Healthcare Technology Report. This prestigious recognition highlights the quality and depth of talent within Zynex.
- PR Newswire
Zynex Reports First Quarter 2024 Financial Results
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended March 31, 2024.
